CD73 Promotes Chronic Lymphocytic Leukemia

SIMPLE SUMMARY: Many patients with chronic lymphocytic leukemia (CLL) still fail current therapies. CD73 is a novel therapeutic target for solid tumors, but its role in CLL remains unclear. The aim of our study was to investigate the therapeutic potential of targeting CD73 in CLL. Using genetically...

Descripción completa

Detalles Bibliográficos
Autores principales: Allard, David, Chrobak, Pavel, Bareche, Yacine, Allard, Bertrand, Tessier, Priscilla, Bergeron, Marjorie A., Johnson, Nathalie A., Stagg, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264813/
https://www.ncbi.nlm.nih.gov/pubmed/35804900
http://dx.doi.org/10.3390/cancers14133130

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264813/
https://www.ncbi.nlm.nih.gov/pubmed/35804900
http://dx.doi.org/10.3390/cancers14133130

Ejemplares similares